Changes of lysosomes in the earliest stages of the development of atherosclerosis

Journal of Cellular and Molecular Medicine

Volumn 17, Issue 5, 2013, Pages 626-635

  Bobryshev, Yuri V ^a,b,c   Shchelkunova, Tatyana A ^d   Morozov, Ivan A ^e   Rubtsov, Petr M ^e   Sobenin, Igor A ^f,g   Orekhov, Alexander N ^c,g   Smirnov, Alexander N ^d  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b UNIVERSITY OF WESTERN SYDNEY   (Australia)

^c Institute for Atherosclerosis Research   (Russian Federation)

^d MOSCOW STATE UNIVERSITY   (Russian Federation)

^e ENGELHARDT INSTITUTE OF MOLECULAR BIOLOGY   (Russian Federation)

^f INSTITUTE OF EXPERIMENTAL CARDIOLOGY   (Russian Federation)

^g INSTITUTE OF GENERAL PATHOLOGY AND PATHOPHYSIOLOGY   (Russian Federation)

Author keywords

Aorta; Atherosclerosis; CD68; Fatty streak; Initial lesion; Intima; Lysosomes

Indexed keywords

CD68 ANTIGEN, HUMAN; DIFFERENTIATION ANTIGEN; LEUKOCYTE ANTIGEN; MESSENGER RNA;

ADULT; ARTICLE; ATHEROSCLEROSIS; CELL COMPARTMENTALIZATION; ENDOSOME; FEMALE; GENETICS; HUMAN; IMMUNOHISTOCHEMISTRY; INTIMA; LYSOSOME; MALE; METABOLISM; MIDDLE AGED; PATHOLOGY; ULTRASTRUCTURE;

ADULT; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; ATHEROSCLEROSIS; CELL COMPARTMENTATION; ENDOSOMES; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LYSOSOMES; MALE; MIDDLE AGED; RNA, MESSENGER; TUNICA INTIMA;

EID: 84878360474     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/jcmm.12042     Document Type: Article

References (51)

1. Ross R. Atherosclerosis-an inflammatory disease. N Engl J Med. 1999; 340: 115-26.
2. Stary HC, Chandler AB, Glagov S, et al. A definition of initial, fatty streak, and intermediate lesions of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Circulation. 1994; 89: 2462-78.
3. Stary HC, Chandler AB, Glagov S, et al. A definition of initial, fatty streak, and intermediate lesions of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Arterioscler Thromb. 1994; 14: 840-56.
4. Ross R. Mechanisms of atherosclerosis - a review. Adv Nephrol Necker Hosp. 1990; 19: 79-86.
5. Schwartz SM, Majesky MW, Murry CE. The intima: development and monoclonal responses to injury. Atherosclerosis. 1995; 118(Suppl.): S125-40.
6. Williams KJ, Tabas I. The response-to-retention hypothesis of atherogenesis reinforced. Curr Opin Lipidol. 1998; 9: 471-4.
7. Noll G. Pathogenesis of atherosclerosis: a possible relation to infection. Atherosclerosis. 1998; 140(Suppl. 1): S3-9.
8. Bobryshev YV. Dendritic cells in atherosclerosis: current status of the problem and clinical relevance. Eur Heart J. 2005; 26: 1700-4.
9. Grundtman C, Wick G. The autoimmune concept of atherosclerosis. Curr Opin Lipidol. 2011; 22: 327-34.
10. Bobryshev YV, Orekhov AN. Cellular mechanisms of atherosclerosis: architectonics of vascular lesions and role of dendritic cells. Saarbrücken: Lap Lambert Academic Publishing GmbH & Co. KG, 2012.
11. De Duve C. The significance of lysosomes in pathology and medicine. Proc Inst Med Chic. 1966; 26: 73-6.
12. De Duve C. The role of lysosomes in cellular pathology. Triangle. 1970; 9: 200-8.
13. de Duve C. The participation of lysosomes in the transformation of smooth muscle cells to foamy cells in the aorta of cholesterol fed rabbits. Acta Cardiol. 1974; 20: 9-25.
14. Haley NJ, Fowler S, de Duve C. Lysosomal acid cholesteryl esterase activity in normal and lipid-laden aortic cells. J Lipid Res. 1980; 21: 961-9.
15. Kruth HS. Macrophage foam cells and atherosclerosis. Front Biosci. 2001; 6: D429-55.
16. Jerome WG. Lysosomes, cholesterol and atherosclerosis. Clin Lipidol. 2010; 5: 853-65.
17. Jerome WG, Yancey PG. The role of microscopy in understanding atherosclerotic lysosomal lipid metabolism. Microsc Microanal. 2003; 9: 54-67.
18. Bobryshev YV. Monocyte recruitment and foam cell formation in atherosclerosis. Micron. 2006; 37: 208-22.
19. Schultz ML, Tecedor L, Chang M, et al. Clarifying lysosomal storage diseases. Trends Neurosci. 2011; 34: 401-10.
20. Jerome WG. Advanced atherosclerotic foam cell formation has features of an acquired lysosomal storage disorder. Rejuvenation Res. 2006; 9: 245-55.
21. Hasilik A, Wrocklage C, Schröder B. Intracellular trafficking of lysosomal proteins and lysosomes. Int J Clin Pharmacol Ther. 2009; 47: S18-33.
22. Stewart SE, D'Angelo ME, Bird PI. Intercellular communication via the endo-lysosomal system: translocation of granzymes through membrane barriers. Biochim Biophys Acta. 2012; 1824: 59-67.
23. Bobryshev YV, Moisenovich MM, Pustovalova OL, et al. Widespread distribution of HLA-DR-expressing cells in macroscopically undiseased intima of the human aorta: a possible role in surveillance and maintenance of vascular homeostasis. Immunobiology. 2012; 217: 558-68.
24. Bobryshev YV, Lord RS. Langhans cells of human arterial intima: uniform by stellate appearance but different by nature. Tissue Cell. 1996; 28: 177-94.
25. Slot JW, Posthuma G, Chang LY, et al. Quantitative aspects of immunogold labeling in embedded and in nonembedded sections. Am J Anat. 1989; 185: 271-81.
26. Liou W, Geuze HJ, Slot JW. Improving structural integrity of cryosections for immunogold labeling. Histochem Cell Biol. 1996; 106: 41-58.
27. Bobryshev YV. Transdifferentiation of smooth muscle cells into chondrocytes in atherosclerotic arteries in situ: implications for diffuse intimal calcification. J Pathol. 2005; 205: 641-50.
28. Kawasaki M, Nakayama K, Wakatsuki S. Membrane recruitment of effector proteins by Arf and Rab GTPases. Curr Opin Struct Biol. 2005; 15: 681-9.
29. Yoshida S, Hoppe AD, Araki N, et al. Sequential signaling in plasma-membrane domains during macropinosome formation in macrophages. J Cell Sci. 2009; 122: 3250-61.
30. Huynh KK, Eskelinen EL, Scott CC, et al. LAMP proteins are required for fusion of lysosomes with phagosomes. EMBO J. 2007; 26: 313-24.
31. Pols MS, Klumperman J. Trafficking and function of the tetraspanin CD63. Exp Cell Res. 2009; 315: 1584-92.
32. Saito N, Pulford KA, Breton-Gorius J, et al. Ultrastructural localization of the CD68 macrophage-associated antigen in human blood neutrophils and monocytes. Am J Pathol. 1991; 139: 1053-9.
33. Komatsu M, Ichimura Y. Physiological significance of selective degradation of p62 by autophagy. FEBS Lett. 2010; 584: 1374-8.
34. Gough PJ, Gordon S, Greaves DR. The use of human CD68 transcriptional regulatory sequences to direct high-level expression of class A scavenger receptor in macrophages in vitro and in vivo. Immunology. 2001; 103: 351-61.
35. Kunisch E, Fuhrmann R, Roth A, et al. Macrophage specificity of three anti-CD68 monoclonal antibodies (KP1, EBM11, and PGM1) widely used for immunohistochemistry and flow cytometry. Ann Rheum Dis. 2004; 63: 774-84.
36. Gui T, Shimokado A, Sun Y, et al. Diverse roles of macrophages in atherosclerosis: from inflammatory biology to biomarker discovery. Mediators Inflamm. 2012; 2012: 693083.
37. Shchelkunova TA, Morozov IA, Rubtsov PM, et al. Comparative contents of mRNAs of sex steroid receptors and enzymes of their metabolism in arterial walls of men. Biochemistry. 2008; 73: 920-8.
38. Shchelkunova TA, Albert EA, Morozov IA, et al. Contents of mRNAs encoding endosome/lysosome components in normal human aorta and in stage II of atherogenesis: a hidden regulation. Biochemistry. 2011; 76: 1178-84.
39. Ishii T, Wallace AM, Zhang X, et al. Stability of housekeeping genes in alveolar macrophages from COPD patients. Eur Respir J. 2006; 27: 300-6.
40. Shashkin P, Dragulev B, Ley K. Macrophage differentiation to foam cells. Curr Pharm Des. 2005; 11: 3061-72.
41. Gelman BB, Davis MH, Morris RE, et al. Structural changes in lysosomes from cultured human fibroblasts in Duchenne's muscular dystrophy. J Cell Biol. 1981; 88: 329-37.
42. Samuels S, Korey SR, Gonatas J, et al. Studies in Tay-Sachs disease. IV. Membranous cytoplasmic bodies. J Neuropathol Exp Netrol. 1963; 22: 81-97.
43. Stern J. The formation of sulfatide inclusions in organized nervous tissue culture. Lab Invest. 1973; 28: 87-95.
44. Hanai J, Leroy J, O'Brien JS. Ultrastructure of cultured fibroblasts in I-cell disease. Am J Dis Child. 1971; 122: 34-8.
45. Orekhov AN, Andreeva ER, Andrianova IV, et al. Peculiarities of cell composition and cell proliferation in different type atherosclerotic lesions in carotid and coronary arteries. Atherosclerosis. 2010; 212: 436-43.
46. Razzhevaǐkin VN. The evolutionary optimality principle as a tool to model structured biological systems. Zh Obshch Biol. 2010; 71: 75-84.
47. Sedov KR, Gorban' AN, Petushkova EV, et al. Correlation adaptometry as a method of screening of the population. Vestn Akad Med Nauk SSSR. 1988; 10: 69-75.
48. Baevsky PM. Prediction of states on the verge of the norm and pathology. Moscow: Medicine, 1979.
49. Majno G, Joris I. Cells, tissues, and disease: principles of general pathology. 2nd edn. New York: Oxford University Press, 2004.
50. Dell'Angelica EC, Mullins C, Caplan S, et al. Lysosome-related organelles. FASEB J. 2000; 14: 1265-78.
51. Huizing M, Helip-Wooley A, Westbroek W, et al. Disorders of lysosome-related organelle biogenesis: clinical and molecular genetics. Annu Rev Genomics Hum Genet. 2008; 9: 359-86.